Klein and Associates

Hagerstown, Maryland 21740

0 studies enrolling now · 4 studies all time

What they study most

Autoimmunity, Inflammation, Polymyalgia Rheumatica, Systemic Lupus Erythematosus

Studies at this site

• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) — Running, not enrolling
• Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) — Completed
• An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus — Completed